Bryan K. Yamamoto, MS, PhD
Robert B. Forney Professor Emeritus of Toxicology
Dr. Yamamoto was an Assistant and Associate Professor with tenure in the Department of Pharmacology at the Northeastern Ohio Universities College of Medicine. Subsequently, he was Professor and Director of the Program in Basic and Clinical Neurosciences in the Department of Psychiatry at Case Western Reserve University School of Medicine before moving to Boston University School of Medicine as Professor and Director of the Laboratory of Neurochemistry in the Department of Pharmacology. In 2008, he joined the Department of Neurosciences at the University of Toledo College of Medicine as Chair and Professor.In 2015, he was appointed the Chair of the Department of Pharmacology and Toxicology and the Robert B. Forney Professor of Toxicology at the Indiana University School of Medicine. Dr. Yamamoto has served and continues to serve as a regular and ad hoc member of NIH Study Sections and is a member of several advisory boards of NIH-sponsored research centers and programs. He also is on the editorial boards of several journals.
Titles & Appointments
- Robert B. Forney Professor Emeritus of Toxicology
- Professor Emeritus of Pharmacology & Toxicology
Education1985 FEL Clinical Pharmacology Postdoctoral Fellowship, University of Colorado School of Medicine1981 PhD Syracuse University1977 MS California State University, Fullerton1975 BA University of California, Los Angeles
Research in his lab has focused on how drugs of abuse affect the neurochemistry of brain. His research has been funded continuously by the National Institutes of Health. He has studied how amphetamines and their interaction with stress alterbrain function and produce damage to regions of the brain that are critically involved in controlling movement and memory processes. More specifically, he is interested in how oxidative, mitochondrial, inflammatory and excitatory processes converge to damage the dopamine and serotonin systems in the brain and how antagonism of these processes are mitigate their neurodegenerative effects. His laboratory also demonstrated that stress and the peripheral inflammatory effects of drugs of abuse mediate its neurotoxicity independent of the direct action of methamphetamine on the brain.
PublicationsMDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate.
Huff CL; Morano RL; Herman JP; Yamamoto BK; Gudelsky GA; Neurotoxicology 2016 Oct 20Peripheral ammonia and blood brain barrier structure and function after methamphetamine.
Northrop NA; Halpin LE; Yamamoto BK; Neuropharmacology 2016 Mar 103,4-methylenedioxymethamphetamine increases excitability in the dentate gyrus: role of 5HT2A receptor-induced PGE2 signaling.
Collins SA; Huff C; Chiaia N; Gudelsky GA; Yamamoto BK; Journal of neurochemistry 2016 Jan 19Protracted effects of chronic stress on serotonin-dependent thermoregulation.
Natarajan R; Northrop NA; Yamamoto BK; Stress (Amsterdam, Netherlands) 2015 Sep 28Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats.
Das SC; Yamamoto BK; Hristov AM; Sari Y; Neuropharmacology 2015 May 19Methamphetamine effects on blood-brain barrier structure and function.
Northrop NA; Yamamoto BK; Frontiers in neuroscience 2015 Mar 4Behavioral impairments and serotonin reductions in rats after chronic L-dopa.
Stansley BJ; Yamamoto BK; Psychopharmacology 2015 Jun 3MDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors.
Collins SA; Gudelsky GA; Yamamoto BK; European journal of pharmacology 2015 Apr 30Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus.
Stansley BJ; Yamamoto BK; The Journal of pharmacology and experimental therapeutics 2014 Sep 11Effects of stress and MDMA on hippocampal gene expression.
Weber GF; Johnson BN; Yamamoto BK; Gudelsky GA; BioMed research international 2014 Jan 9Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity.
Halpin LE; Northrop NA; Yamamoto BK; Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2013 Oct 29Methamphetamine causes acute hyperthermia-dependent liver damage.
Halpin LE; Gunning WT; Yamamoto BK; Pharmacology research & perspectives 2013 Oct 1Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.
Northrop NA; Yamamoto BK; Neuropharmacology 2013 May 2Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.
Halpin LE; Collins SA; Yamamoto BK; Life sciences 2013 Jul 24Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake.
Huff C; Bhide N; Schroering A; Yamamoto BK; Gudelsky GA; Brain research bulletin 2013 Jan 12Peripheral ammonia as a mediator of methamphetamine neurotoxicity.
Halpin LE; Yamamoto BK; The Journal of neuroscience : the official journal of the Society for Neuroscience 2012 Sep 19L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells.
Stansley BJ; Yamamoto BK; Neuropharmacology 2012 Nov 27MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase.
Anneken JH; Cunningham JI; Collins SA; Yamamoto BK; Gudelsky GA; Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2012 Nov 18Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier.
Northrop NA; Yamamoto BK; Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2012 Jul 26Methamphetamine-induced oxidation of proteins and alterations in protein processing.
Yamamoto BK; Yang FC; Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2012 JanResveratrol attenuates L-DOPA-induced hydrogen peroxide toxicity in neuronal cells.
Peritore CS; Ho A; Yamamoto BK; Schaus SE; Neuroreport 2012 Dec 5The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.
Natarajan R; Yamamoto BK; Basal ganglia 2011 Jul 1Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo.
Moszczynska A; Yamamoto BK; Journal of neurochemistry 2011 Jan 19Alterations in adult behavioral responses to cocaine and dopamine transporters following juvenile exposure to methamphetamine.
McFadden L; Yamamoto BK; Matuszewich L; Behavioural brain research 2010 Sep 9Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
Johnson BN; Yamamoto BK; The Journal of pharmacology and experimental therapeutics 2010 Jul 15Amphetamine toxicities: classical and emerging mechanisms.
Yamamoto BK; Moszczynska A; Gudelsky GA; Annals of the New York Academy of Sciences 2010 FebRegulation of glutamate release by a7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals.
Northrop NA; Smith LP; Yamamoto BK; Eyerman DJ; The Journal of pharmacology and experimental therapeutics 2010 Dec 15Neuroimmune pharmacology from a neuroscience perspective.
Northrop NA; Yamamoto BK; Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2010 Aug 18Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine.
Doyle JR; Yamamoto BK; Psychoneuroendocrinology 2009 Oct 29MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning.
Cunningham JI; Raudensky J; Tonkiss J; Yamamoto BK; Behavioral neuroscience 2009 OctRepeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain.
Bhide NS; Lipton JW; Cunningham JI; Yamamoto BK; Gudelsky GA; Brain research 2009 Jun 23Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone.
Johnson BN; Yamamoto BK; Neuroscience 2009 Feb 3Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum.
Tata DA; Yamamoto BK; Synapse (New York, N.Y.) 2008 MayThe role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.
Yamamoto BK; Raudensky J; Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2008 Aug 15Gender differences in zebrafish responses to cocaine withdrawal.
López Patiño MA; Yu L; Yamamoto BK; Zhdanova IV; Physiology & behavior 2008 Apr 8Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.
Gudelsky GA; Yamamoto BK; Pharmacology, biochemistry, and behavior 2007 Oct 16Haloperidol treatment after high-dose methamphetamine administration is excitotoxic to GABA cells in the substantia nigra pars reticulata.
Hatzipetros T; Raudensky JG; Soghomonian JJ; Yamamoto BK; The Journal of neuroscience : the official journal of the Society for Neuroscience 2007 May 30Effects of chronic unpredictable stress on monoamine transporter immunoreactivity and methamphetamine-induced dopamine release in the nucleus accumbens shell.
Raudensky J; Yamamoto BK; Synapse (New York, N.Y.) 2007 MayDynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release.
Mark KA; Quinton MS; Russek SJ; Yamamoto BK; The Journal of neuroscience : the official journal of the Society for Neuroscience 2007 Jun 20Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function.
Raudensky J; Yamamoto BK; Brain research 2007 Jan 2A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine.
Eyerman DJ; Yamamoto BK; Journal of neurochemistry 2007 Aug 7Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia.
Tata DA; Raudensky J; Yamamoto BK; The European journal of neuroscience 2007 AugNeurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats.
Quinton MS; Yamamoto BK; Psychopharmacology 2007 Apr 26Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction.
Tata DA; Yamamoto BK; Addiction (Abingdon, England) 2007 AprCauses and consequences of methamphetamine and MDMA toxicity.
Quinton MS; Yamamoto BK; The AAPS journal 2006 May 12Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra.
Hatzipetros T; Yamamoto BK; Brain research 2006 Mar 3L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions.
Breier JM; Bankson MG; Yamamoto BK; The Journal of neuroscience : the official journal of the Society for Neuroscience 2006 Jan 4Methamphetamine-induced spectrin proteolysis in the rat striatum.
Staszewski RD; Yamamoto BK; Journal of neurochemistry 2006 Jan 17Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor.
Amato JL; Bankson MG; Yamamoto BK; Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006 Aug 2Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
Broom SL; Yamamoto BK; Psychopharmacology 2005 Oct 12Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite.
Brown JM; Quinton MS; Yamamoto BK; Journal of neurochemistry 2005 Aug 8Amphetamine neurotoxicity: cause and consequence of oxidative stress.
Yamamoto BK; Bankson MG; Critical reviews in neurobiology 2005Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
Darvesh AS; Yamamoto BK; Gudelsky GA; The Journal of pharmacology and experimental therapeutics 2004 Sep 29Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
Bankson MG; Yamamoto BK; Journal of neurochemistry 2004 NovClozapine prolongs hypotonic immobility in rats with bilateral 6-hydroxydopamine lesions of the striatum.
Jaskiw GE; Hussain G; Stephans SE; Yamamoto BK; Meltzer HY; Neuroscience letters 2004 May 13Tyrosine augments clozapine-induced dopamine release in the medial prefrontal cortex of the rat in vivo: effects of access to food.
Jaskiw GE; Simpson C; Bongiovanni R; Yamamoto BK; Neuroscience letters 2004 Feb 26High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.
Mark KA; Soghomonian JJ; Yamamoto BK; The Journal of neuroscience : the official journal of the Society for Neuroscience 2004 Dec 15Effects of chronic stress on methamphetamine-induced dopamine depletions in the striatum.
Matuszewich L; Yamamoto BK; Annals of the New York Academy of Sciences 2004 DecLobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK; The Journal of pharmacology and experimental therapeutics 2004 Aug 26Chronic stress augments the long-term and acute effects of methamphetamine.
Matuszewich L; Yamamoto BK; Neuroscience 2004Pharmacokinetics of systemically administered tyrosine: a comparison of serum, brain tissue and in vivo microdialysate levels in the rat.
Bongiovanni R; Yamamoto BK; Simpson C; Jaskiw GE; Journal of neurochemistry 2003 OctLong-lasting effects of chronic stress on DOI-induced hyperthermia in male rats.
Matuszewich L; Yamamoto BK; Psychopharmacology 2003 May 27Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress.
Brown JM; Yamamoto BK; Pharmacology & therapeutics 2003 JulCatecholaminergic microcircuitry controlling the output of airway-related vagal preganglionic neurons.
Haxhiu MA; Kc P; Neziri B; Yamamoto BK; Ferguson DG; Massari VJ; Journal of applied physiology (Bethesda, Md. : 1985) 2003 Jan 3Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine.
Gudelsky GA; Yamamoto BK; Methods in molecular medicine 2003Activation of the midbrain periaqueductal gray induces airway smooth muscle relaxation.
Haxhiu MA; Yamamoto BK; Dreshaj IA; Ferguson DG; Journal of applied physiology (Bethesda, Md. : 1985) 2002 AugAltered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine.
Matuszewich L; Filon ME; Finn DA; Yamamoto BK; Neuroscience 2002Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study.
Jaskiw GE; Collins KA; Pehek EA; Yamamoto BK; Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001 JulImproved method for the measurement of large neutral amino acids in biological matrices.
Bongiovanni R; Yamamoto BK; Jaskiw GE; Journal of chromatography. B, Biomedical sciences and applications 2001 Apr 25Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate.
Nixdorf WL; Burrows KB; Gudelsky GA; Yamamoto BK; Journal of neurochemistry 2001 AprAscorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
Shankaran M; Yamamoto BK; Gudelsky GA; Synapse (New York, N.Y.) 2001 AprCentral administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines.
Burrows KB; Nixdorf WL; Yamamoto BK; The Journal of pharmacology and experimental therapeutics 2000 MarRapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration.
Burrows KB; Gudelsky G; Yamamoto BK; European journal of pharmacology 2000 Jun 9Alterations in respiratory behavior, brain neurochemistry and receptor density induced by pharmacologic suppression of sleep in the neonatal period.
Thomas AJ; Erokwu BO; Yamamoto BK; Ernsberger P; Bishara O; Strohl KP; Brain research. Developmental brain research 2000 Apr 14Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum.
Shankaran M; Yamamoto BK; Gudelsky GA; Journal of neurochemistry 1999 JunInvolvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine.
Shankaran M; Yamamoto BK; Gudelsky GA; European journal of pharmacology 1999 Dec 3Modulation of GABA release by dopamine in the substantia nigra.
Matuszewich L; Yamamoto BK; Synapse (New York, N.Y.) 1999 AprThe effects of methamphetamine on the production of free radicals and oxidative stress.
Yamamoto BK; Zhu W; The Journal of pharmacology and experimental therapeutics 1998 OctKetamine blocks a conditioned taste aversion (CTA) in neonatal rats.
Mickley GA; Schaldach MA; Snyder KJ; Balogh SA; Len T; Neimanis K; Goulis P; Hug J; Sauchak K; Remmers-Roeber DR; Walker C; Yamamoto BK; Physiology & behavior 1998 Jun 1The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations.
Feldpausch DL; Needham LM; Stone MP; Althaus JS; Yamamoto BK; Svensson KA; Merchant KM; The Journal of pharmacology and experimental therapeutics 1998 JulRegulation of extracellular dopamine by the norepinephrine transporter.
Yamamoto BK; Novotney S; Journal of neurochemistry 1998 JulSubstrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum.
Stephans SE; Whittingham TS; Douglas AJ; Lust WD; Yamamoto BK; Journal of neurochemistry 1998 AugModulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA; The Journal of pharmacology and experimental therapeutics 1995 JunEffect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats.
Lowy MT; Wittenberg L; Yamamoto BK; Journal of neurochemistry 1995 JulBrain region effects of clozapine on amino acid and monoamine transmission.
Yamamoto BK; Pehek EA; Meltzer HY; The Journal of clinical psychiatry 1994 SepPotentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists.
Gudelsky GA; Yamamoto BK; Nash JF; European journal of pharmacology 1994 Nov 3Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Meltzer HY; Chai BL; Thompson PA; Yamamoto BK; The Journal of pharmacology and experimental therapeutics 1994 MarMethamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
Stephans SE; Yamamoto BK; Synapse (New York, N.Y.) 1994 JulDifferential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.
Yamamoto BK; Cooperman MA; The Journal of neuroscience : the official journal of the Society for Neuroscience 1994 JulDifferential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen.
Pehek EA; Yamamoto BK; Journal of neurochemistry 1994 DecEffect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats.
Nash JF; Yamamoto BK; Brain research 1993 Nov 5Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus.
Lowy MT; Gault L; Yamamoto BK; Journal of neurochemistry 1993 NovA system for measuring electrophysiological multiple unit activity and extracellular dopamine concentration at single electrodes.
Glynn GE; Yamamoto BK; Journal of neuroscience methods 1993 MayThe atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.
Pehek EA; Meltzer HY; Yamamoto BK; European journal of pharmacology 1993 Aug 10Extracellular glutamate levels increase with age in the lateral striatum: potential involvement of presynaptic D-2 receptors.
Donzanti BA; Hite JF; Yamamoto BK; Synapse (New York, N.Y.) 1993 AprThe effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo.
Yamamoto BK; Meltzer HY; The Journal of pharmacology and experimental therapeutics 1992 OctMethamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
Nash JF; Yamamoto BK; Brain research 1992 May 29Dopaminergic modulation of glutamate release in striatum as measured by microdialysis.
Yamamoto BK; Davy S; Journal of neurochemistry 1992 MaySelective subregional dopamine depletions in the rat caudate-putamen following nigrostriatal lesions.
Pehek EA; Crock R; Yamamoto BK; Synapse (New York, N.Y.) 1992 AprA neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis.
Yamamoto BK; Pehek EA; Brain research 1990 Jan 8Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo.
Pehek EA; Schechter MD; Yamamoto BK; Neuropharmacology 1990 DecIn vivo neurochemical and anatomical heterogeneity of the dopamine uptake system in the rat caudate putamen.
Glynn GE; Yamamoto BK; Brain research 1989 Mar 6Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.
Spanos LJ; Yamamoto BK; Pharmacology, biochemistry, and behavior 1989 AprInhibition of rat brain pyruvate dehydrogenase by thiamine analogs.
Kandiko CT; Smith D; Yamamoto BK; Biochemical pharmacology 1988 Nov 15The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.
Yamamoto BK; Spanos LJ; European journal of pharmacology 1988 Mar 29A rapid and simple HPLC microassay for biogenic amines in discrete brain regions.
Donzanti BA; Yamamoto BK; Pharmacology, biochemistry, and behavior 1988 JulAn improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates.
Donzanti BA; Yamamoto BK; Life sciences 1988In vivo electrochemical determination of extracellular dopamine in the caudate of freely-moving rats after a low dose of ethanol.
Signs SA; Yamamoto BK; Schechter MD; Neuropharmacology 1987 NovRegional brain dopamine metabolism: a marker for the speed, direction, and posture of moving animals.
Freed CR; Yamamoto BK; Science (New York, N.Y.) 1985 Jul 5Unilateral activation of caudate tyrosine hydroxylase during voluntary circling behavior.
Morgan ME; Yamamoto BK; Freed CR; Journal of neurochemistry 1984 SepCaudate electrochemical response following amphetamine administration in pigtail monkeys.
Cheney-Thamm J; Reite M; Alianiello EA; Yamamoto BK; Capitanio JP; Freed CR; Life sciences 1984 Oct 1Reversal of amphetamine-induced circling preference in trained circling rats.
Yamamoto BK; Freed CR; Life sciences 1984 Feb 13Asymmetric dopamine and serotonin metabolism in nigrostriatal and limbic structures of the trained circling rat.
Yamamoto BK; Freed CR; Brain research 1984 Apr 9Normal rats trained to circle show asymmetric caudate dopamine release.
Yamamoto BK; Lane RF; Freed CR; Life sciences 1982 Jun 21The trained circling rat: a model for inducing unilateral caudate dopamine metabolism.
Yamamoto BK; Freed CR; Nature 1982 Jul 29Drug and food-deprivation modulation of activity in rats given chronic dietary lead: significance of type of activity measure.
Yamamoto BK; Kutscher CL; Pharmacology, biochemistry, and behavior 1981 SepThe use of fluoride for the prevention of chronic intracranial implant dislodgment.
Yamamoto BK; Kutscher CL; Pharmacology, biochemistry, and behavior 1981 OctUsing profiles of saccharin and water drinking to detect and discriminate actions of drugs and toxicants.
Yamamoto BK; Kutscher CL; Pharmacology, biochemistry, and behavior 1980 OctIncreased and decreased preference for saccharin immediately following injections of various agents.
Kutscher CL; Yamamoto BK; Hamburger JN; Physiology & behavior 1979 SepA frequency analysis of behavior components of the serotonin syndrome produced by p-chloroamphetamine.
Kutscher CL; Yamamoto BK; Pharmacology, biochemistry, and behavior 1979 Dec
Professional OrganizationsFederation of Associated Societies of Experimental BiologyNew York Academy of SciencesSociety for Neuroscience
AwardsOrg: University of Oklahoma
Desc: Distinguished Lecturer
Org: Indiana University School of Medicine
Desc: Robert B. Forney Professor of Toxicology
Org: Society for Neuroimmune Pharmacology
Desc: Plenary Lecturer
Org: University of Toledo College of Medicine
Desc: Raymond and Beverly Sackler Distinguished Professor of Neurosciences
Org: Society for Neuroimmune Pharmacology
Desc: Plenary Lecturer
Org: International Conference and Exhibition on Addiction Research and Therapy
Desc: Plenary Lecturer
Org: Inaugural Reward and Deficiency Syndrome Summit (RDS Summit)
Desc: Plenary Lecturer